Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab
Steffen Pfeuffer(Justus-Liebig-Universität Gießen), Sven G. Meuth(University Hospital Münster), Konstanze Kleinschnitz(University of Duisburg-Essen), Jens Ingwersen(Düsseldorf University Hospital), Melanie Korsen(Heinrich Heine University Düsseldorf), Refik Pul, Saskia Räuber(Düsseldorf University Hospital), Orhan Aktaş(Heinrich Heine University Düsseldorf), Tobias Ruck(BG University Hospital Bergmannsheil Bochum), Ludwig Kappos(University Hospital of Basel), Hans‐Peter Hartung(The University of Sydney), Alice Willison(Düsseldorf University Hospital), Christoph Kleinschnitz(Essen University Hospital), Leoni Rolfes(University Hospital Münster), Simon Schieferdecker(The University of Sydney)
Cited by 10
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k